• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆症患者的抗高血压治疗。

Antihypertensive treatment in people with dementia.

作者信息

van der Wardt Veronika, Logan Pip, Conroy Simon, Harwood Rowan, Gladman John

机构信息

Division of Rehabilitation and Ageing, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Division of Rehabilitation and Ageing, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

出版信息

J Am Med Dir Assoc. 2014 Sep;15(9):620-9. doi: 10.1016/j.jamda.2014.03.005. Epub 2014 Apr 20.

DOI:10.1016/j.jamda.2014.03.005
PMID:24755477
Abstract

BACKGROUND

The range and magnitude of potential benefits and harms of antihypertensive treatment in people with dementia has not been previously established.

METHODS

A scoping review to identify potential domains of benefits and harms of antihypertensive therapy in people with dementia was undertaken. Systematic reviews of these domains were undertaken to examine the magnitude of the benefits or harms.

RESULTS

Potential outcome domains identified in the 155 papers in the scoping review were cardiovascular events, falls, fractures and syncope, depression, orthostatic hypotension, behavioral disturbances, polypharmacy risks, kidney problems, sleep problems, interactions with cholinesterase inhibitors, and pain. The systematic reviews across these domains identified relatively few studies done in people with dementia, and no convincing evidence of safety, benefit, or harm across any of them.

DISCUSSION

Given the lack of firm evidence of benefits or harm from antihypertensive therapy in people with dementia and the weak evidence for benefits in people over 80 years of age, the current presumption that the favorable evidence drawn from the treatment of nondemented people should be extrapolated to those with dementia is contentious. There is sufficient evidence to warrant particular caution and further research into treatment in this group of patients.

摘要

背景

此前尚未确定抗高血压治疗对痴呆症患者潜在益处和危害的范围及程度。

方法

进行了一项范围综述,以确定抗高血压治疗对痴呆症患者潜在的益处和危害领域。对这些领域进行了系统综述,以研究益处或危害的程度。

结果

范围综述中155篇论文确定的潜在结果领域包括心血管事件、跌倒、骨折和晕厥、抑郁、体位性低血压、行为障碍、多重用药风险、肾脏问题、睡眠问题、与胆碱酯酶抑制剂的相互作用以及疼痛。对这些领域的系统综述发现,针对痴呆症患者开展的研究相对较少,而且没有令人信服的证据表明在任何一个领域存在安全性、益处或危害。

讨论

鉴于缺乏抗高血压治疗对痴呆症患者有益或有害的确凿证据,以及对80岁以上人群有益的证据不足,目前认为从非痴呆症患者治疗中得出的有利证据应外推至痴呆症患者的假设存在争议。有足够的证据表明对此类患者的治疗需要格外谨慎并进一步研究。

相似文献

1
Antihypertensive treatment in people with dementia.痴呆症患者的抗高血压治疗。
J Am Med Dir Assoc. 2014 Sep;15(9):620-9. doi: 10.1016/j.jamda.2014.03.005. Epub 2014 Apr 20.
2
Withdrawal of antihypertensive drugs in older people.老年人停用抗高血压药物
Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD012572. doi: 10.1002/14651858.CD012572.pub2.
3
Withdrawal of antihypertensive drugs in older people.老年人停用抗高血压药物
Cochrane Database Syst Rev. 2025 Mar 31;3(3):CD012572. doi: 10.1002/14651858.CD012572.pub3.
4
Antihypertensives in dementia: Good or bad for the brain?抗痴呆药物:对大脑有益还是有害?
J Cereb Blood Flow Metab. 2023 Oct;43(10):1796-1799. doi: 10.1177/0271678X231179421. Epub 2023 May 27.
5
Randomised controlled trials of antihypertensive therapy: does exclusion of orthostatic hypotension alter treatment effect? A systematic review and meta-analysis.随机对照降压治疗试验:排除直立性低血压是否改变治疗效果?系统评价和荟萃分析。
Age Ageing. 2023 Apr 1;52(4). doi: 10.1093/ageing/afad044.
6
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.用于治疗高血压的一线肾素-血管紧张素系统抑制剂与其他一线抗高血压药物类别对比
Cochrane Database Syst Rev. 2018 Nov 14;11(11):CD008170. doi: 10.1002/14651858.CD008170.pub3.
7
The evidence for treating hypertension in older people with dementia: a systematic review.治疗老年痴呆症患者高血压的证据:系统评价。
J Hum Hypertens. 2014 May;28(5):283-7. doi: 10.1038/jhh.2013.107. Epub 2013 Nov 7.
8
Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 - benefits and adverse events in older and younger patients with hypertension: overview, meta-analyses and meta-regression analyses of randomized trials.降压治疗对心血管结局和死亡率的影响:13 - 老年和年轻高血压患者的获益和不良反应:随机试验的概述、荟萃分析和荟萃回归分析。
J Hypertens. 2018 Aug;36(8):1622-1636. doi: 10.1097/HJH.0000000000001787.
9
Glucose-Dementia Association Is Consistent Over Blood Pressure/Antihypertensive Groups.血糖与痴呆关联不受血压/降压药物分组影响。
J Alzheimers Dis. 2021;80(1):79-90. doi: 10.3233/JAD-201138.
10
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.高血压患者无既往脑血管疾病的药物治疗对预防认知障碍和痴呆。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD004034. doi: 10.1002/14651858.CD004034.pub4.

引用本文的文献

1
Uncoupling of Ca sparks from BK channels in cerebral arteries underlies hypoperfusion in hypertension-induced vascular dementia.高血压诱导血管性痴呆中脑动脉的钙火花与 BK 通道解偶联导致低灌注。
Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2307513120. doi: 10.1073/pnas.2307513120. Epub 2023 Aug 7.
2
Antihypertensives in dementia: Good or bad for the brain?抗痴呆药物:对大脑有益还是有害?
J Cereb Blood Flow Metab. 2023 Oct;43(10):1800-1802. doi: 10.1177/0271678X221133473. Epub 2022 Oct 25.
3
Differential restoration of functional hyperemia by antihypertensive drug classes in hypertension-related cerebral small vessel disease.
降压药类别对高血压相关脑小血管病患者功能性充血的恢复作用存在差异。
J Clin Invest. 2021 Sep 15;131(18). doi: 10.1172/JCI149029.
4
The longitudinal association between the use of antihypertensive medications and 24-hour sleep in nursing homes: results from the randomized controlled COSMOS trial.疗养院中使用抗高血压药物与24小时睡眠之间的纵向关联:随机对照COSMOS试验的结果
BMC Geriatr. 2021 Jul 18;21(1):430. doi: 10.1186/s12877-021-02317-4.
5
Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden.居住在瑞典北部养老院中有认知障碍的人群中心血管药物的使用情况。
Eur J Clin Pharmacol. 2020 Apr;76(4):525-537. doi: 10.1007/s00228-019-02778-y. Epub 2020 Jan 8.
6
Potentially inappropriate prescribing in dementia: a state-of-the-art review since 2007.痴呆症潜在不适当处方:自 2007 年以来的最新综述。
BMJ Open. 2020 Jan 2;10(1):e029172. doi: 10.1136/bmjopen-2019-029172.
7
Diagnostic accuracy of office blood pressure compared to home blood pressure in patients with mild cognitive impairment and dementia.在轻度认知障碍和痴呆患者中,与家庭血压相比,诊室血压的诊断准确性。
Eur J Cardiovasc Nurs. 2019 Oct;18(7):637-642. doi: 10.1177/1474515119855822. Epub 2019 Jul 2.
8
Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension.尼伐地平治疗轻中度阿尔茨海默病患者的降压作用不会增加直立性低血压的患病率。
J Am Heart Assoc. 2019 May 21;8(10):e011938. doi: 10.1161/JAHA.119.011938.
9
Blood Pressure and Cerebral Blood Flow in Alzheimer Disease.阿尔茨海默病中的血压与脑血流量
Hypertension. 2018 Jul;72(1):68-69. doi: 10.1161/HYPERTENSIONAHA.118.11019. Epub 2018 May 29.
10
Withdrawal of antihypertensive therapy in people with dementia: feasibility study.痴呆症患者停用抗高血压治疗:可行性研究
Pilot Feasibility Stud. 2018 Jan 9;4:29. doi: 10.1186/s40814-017-0221-0. eCollection 2018.